Advertisement

The Changing Epidemiology of Invasive Fungal Infections

  • David A. EnochEmail author
  • Huina Yang
  • Sani H. Aliyu
  • Christianne Micallef
Part of the Methods in Molecular Biology book series (MIMB, volume 1508)

Abstract

Invasive fungal infections (IFI) are an emerging problem worldwide with invasive candidiasis and candidemia responsible for the majority of cases. This is predominantly driven by the widespread adoption of aggressive immunosuppressive therapy among certain patient populations (e.g., chemotherapy, transplants) and the increasing use of invasive devices such as central venous catheters (CVCs). The use of new immune modifying drugs has also opened up an entirely new spectrum of patients at risk of IFIs. While the epidemiology of candida infections has changed in the last decade, with a gradual shift from C. albicans to non-albicans candida (NAC) strains which may be less susceptible to azoles, these changes vary between hospitals and regions depending on the type of population risk factors and antifungal use. In certain parts of the world, the incidence of IFI is strongly linked to the prevalence of other disease conditions and the ecological niche for the organism; for instance cryptococcal and pneumocystis infections are particularly common in areas with a high prevalence of HIV disease. Poorly controlled diabetes is a major risk factor for invasive mould infections. Environmental factors and trauma also play a unique role in the epidemiology of mould infections, with well-described hospital outbreaks linked to the use of contaminated instruments and devices. Blastomycosis is associated with occupational exposure (e.g., forest rangers) and recreational activities (e.g., camping and fishing).

The true burden of IFI is probably an underestimate because of the absence of reliable diagnostics and lack of universal application. For example, the sensitivity of most blood culture systems for detecting candida is typically 50 %. The advent of new technology including molecular techniques such as 18S ribosomal RNA PCR and genome sequencing is leading to an improved understanding of the epidemiology of the less common mould and dimorphic fungal infections. Molecular techniques are also providing a platform for improved diagnosis and management of IFI.

Many factors affect mortality in IFI, not least the underlying medical condition, choice of therapy, and the ability to achieve early source control. For instance, mortality due to pneumocystis pneumonia in HIV-seronegative individuals is now higher than in seropositive patients. Of significant concern is the progressive increase in resistance to azoles and echinocandins among candida isolates, which appears to worsen the already significant mortality associated with invasive candidiasis. Mortality with mould infections approaches 50 % in most studies and varies depending on the site, underlying disease and the use of antifungal agents such as echinocandins and voriconazole. Nevertheless, mortality for most IFIs has generally fallen with advances in medical technology, improved care of CVCs, improved diagnostics, and more effective preemptive therapy and prophylaxis.

Key words

Candida Cryptococcus Aspergillus Mucor Fusarium Scedosporium Pneumocystis Dimorphic fungi Paracoccidioides Histoplasma Dermatophytes 

Notes

Transparency Declarations

DAE has received funding to attend conferences from MSD, Gilead, and Astellas. SHA has served on UK Advisory Boards for liposomal amphotericin B (Gilead), caspofungin (MSD) and posaconazole (MSD) and has received sponsorship to attend international meetings from Schering-Plough, Gilead, and Wyeth. CM has received travel grants to attend scientific conferences from Astellas, Gilead, Pfizer and Novartis, educational grants from Pfizer and Novartis, attended a Pfizer Advisory Board Meeting and consulted for Astellas. HY has no conflicts of interest.

References

  1. 1.
    Cuenca-Estrella M, Verweij PE, Arendrup MC, Arikan-Akdagli S, Bille J, Donnelly JP, Jensen HE, Lass-Flörl C, Richardson MD, Akova M, Bassetti M, Calandra T, Castagnola E, Cornely OA, Garbino J, Groll AH, Herbrecht R, Hope WW, Kullberg BJ, Lortholary O, Meersseman W, Petrikkos G, Roilides E, Viscoli C, Ullmann AJ, ESCMID Fungal Infection Study Group (2012) ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 18(Suppl 7):9–18Google Scholar
  2. 2.
    Clancy CJ, Nguyen MH (2013) Finding the “missing 50 %” of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 56(9):1284–1292PubMedCrossRefGoogle Scholar
  3. 3.
    Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP (1999) Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29(2):239–244PubMedCrossRefGoogle Scholar
  4. 4.
    Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39(3):309–317PubMedCrossRefGoogle Scholar
  5. 5.
    Gradel KO, Schønheyder HC, Arpi M, Knudsen JD, Ostergaard C, Søgaard M (2014) The Danish Collaborative Bacteraemia Network (DACOBAN) database. Clin Epidemiol 6:301–308PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Cleveland AA, Harrison LH, Farley MM, Hollick R, Stein B, Chiller TM, Lockhart SR, Park BJ (2015) Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008-2013: results from population-based surveillance. PLoS One 10(3):e0120452Google Scholar
  7. 7.
    Pfaller MA, Diekema DJ, Jones RN, Messer SA, Hollis RJ, SENTRY Participants Group (2002) Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J Clin Microbiol 40(3):852–856Google Scholar
  8. 8.
    Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK, Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team (2014) Multistate point-prevalence survey of health care-associated infections. N Engl J Med 370(13):1198–1208PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Ota KV, McGowan KL (2012) Declining incidence of candidemia in a tertiary inpatient pediatric population. J Clin Microbiol 50(3):1048–1050PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Oeser C, Vergnano S, Naidoo R, Anthony M, Chang J, Chow P, Clarke P, Embleton N, Kennea N, Pattnayak S, Reichert B, Scorrer T, Tiron I, Watts T, Sharland M, Heath PT, Neonatal Infection Surveillance Network (neonIN) (2014) Neonatal invasive fungal infection in England 2004-2010. Clin Microbiol Infect 20(9):936–941PubMedCrossRefGoogle Scholar
  11. 11.
    Eggimann P, Que YA, Revelly JP, Pagani JL (2015) Preventing invasive Candida infections. Where could we do better? J Hosp Infect 89(4):302–308Google Scholar
  12. 12.
    Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP, National Nosocomial Infections Surveillance System Hospitals (2002) Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 35(5):627–630PubMedCrossRefGoogle Scholar
  13. 13.
    Kibbler CC, Seaton S, Barnes RA, Gransden WR, Holliman RE, Johnson EM, Perry JD, Sullivan DJ, Wilson JA (2003) Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 54(1):18–24Google Scholar
  14. 14.
    Tortorano AM, Peman J, Bernhardt H, Klingspor L, Kibbler CC, Faure O, Biraghi E, Canton E, Zimmermann K, Seaton S, Grillot R, ECMM Working Group on Candidaemia (2004) Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 23(4):317–322PubMedCrossRefGoogle Scholar
  15. 15.
    Falagas ME, Roussos N, Vardakas KZ (2010) Relative frequency of albicans and the various non-albicans Candida spp. among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis 14(11):e954–e966Google Scholar
  16. 16.
    Alp S, Arikan-Akdagli S, Gulmez D, Ascioglu S, Uzun O, Akova M (2015) Epidemiology of candidaemia in a tertiary care university hospital: 10-year experience with 381 candidaemia episodes between 2001 and 2010. Mycoses 58(8):498–505PubMedCrossRefGoogle Scholar
  17. 17.
    Arendrup MC, Sulim S, Holm A, Nielsen L, Nielsen SD, Knudsen JD, Drenck NE, Christensen JJ, Johansen HK (2011) Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol 49(9):3300–3308PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Asmundsdottir LR, Erlendsdottir H, Gottfredsson M (2013) Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011. J Clin Microbiol 51(3):841–848PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Barchiesi F, Orsetti E, Gesuita R, Skrami E, Manso E, Candidemia Study Group. Epidemiology, clinical characteristics, and outcome of candidemia in a tertiary referral center in Italy from 2010 to 2014. Infection. 2015. [Epub ahead of print]Google Scholar
  20. 20.
    Bartoletti M, Giannella M, Caraceni P, Domenicali M, Ambretti S, Tedeschi S, Verucchi G, Badia L, Lewis RE, Bernardi M, Viale P (2014) Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. J Hepatol 61(1):51–58PubMedCrossRefGoogle Scholar
  21. 21.
    Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, Viscoli C (2011) Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One 6(9):e24198PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Bassetti M, Merelli M, Ansaldi F, de Florentiis D, Sartor A, Scarparo C, Callegari A, Righi E (2015) Clinical and therapeutic aspects of candidemia: a five year single centre study. PLoS One 10(5):e0127534PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Bassetti M, Merelli M, Righi E, Diaz-Martin A, Rosello EM, Luzzati R, Parra A, Trecarichi EM, Sanguinetti M, Posteraro B, Garnacho-Montero J, Sartor A, Rello J, Tumbarello M (2013) Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol 51(12):4167–4172PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Bassetti M, Righi E, Ansaldi F, Merelli M, Scarparo C, Antonelli M, Garnacho-Montero J, Diaz-Martin A, Palacios-Garcia I, Luzzati R, Rosin C, Lagunes L, Rello J, Almirante B, Scotton PG, Baldin G, Dimopoulos G, Nucci M, Munoz P, Vena A, Bouza E, de Egea V, Colombo AL, Tascini C, Menichetti F, Tagliaferri E, Brugnaro P, Sanguinetti M, Mesini A, Sganga G, Viscoli C, Tumbarello M (2015) A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med 41(9):1601–1610PubMedCrossRefGoogle Scholar
  25. 25.
    Ben-Ami R, Olshtain-Pops K, Krieger M, Oren I, Bishara J, Dan M, Wiener-Well Y, Weinberger M, Zimhony O, Chowers M, Weber G, Potasman I, Chazan B, Kassis I, Shalit I, Block C, Keller N, Kontoyiannis DP, Giladi M, Israeli Candidemia Study Group (2012) Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection. Antimicrob Agents Chemother 56(5):2518–2523Google Scholar
  26. 26.
    Berdal JE, Haagensen R, Ranheim T, Bjørnholt JV (2014) Nosocomial candidemia; risk factors and prognosis revisited; 11 years experience from a Norwegian secondary hospital. PLoS One 9(7):e103916PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Bitar D, Lortholary O, Le Strat Y, Nicolau J, Coignard B, Tattevin P, Che D, Dromer F (2014) Population-based analysis of invasive fungal infections, France, 2001-2010. Emerg Infect Dis 20(7):1149–1155PubMedCrossRefGoogle Scholar
  28. 28.
    Caggiano G, Coretti C, Bartolomeo N, Lovero G, De Giglio O, Montagna MT (2015) Candida bloodstream infections in Italy: changing epidemiology during 16 years of surveillance. Biomed Res Int 2015:256580Google Scholar
  29. 29.
    Celebi S, Hacimustafaoglu M, Koksal N, Ozkan H, Cetinkaya M, Ener B (2012) Neonatal candidiasis: results of an 8 year study. Pediatr Int 54(3):341–349PubMedCrossRefGoogle Scholar
  30. 30.
    Cornely OA, Gachot B, Akan H, Bassetti M, Uzun O, Kibbler C, Marchetti O, de Burghgraeve P, Ramadan S, Pylkkanen L, Ameye L, Paesmans M, Donnelly PJ, EORTC Infectious Diseases Group (2015) Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031). Clin Infect Dis 61(3):324–331PubMedCrossRefGoogle Scholar
  31. 31.
    De Rosa FG, Corcione S, Raviolo S, Montrucchio C, Aldieri C, Pagani N, Di Perri G (2015) Candidemia, and infections by Clostridium difficile and carbapenemase-producing Enterobacteriaceae: new enteropathogenetic opportunistic syndromes? Infez Med 23(2):105–116PubMedGoogle Scholar
  32. 32.
    Dzierzanowska-Fangrat K, Romanowska E, Gryniewicz-Kwiatkowska O, Migdał M, Witulska K, Ryżko J, Kaliciński P, Książyk J, Nadkowska P, Dzierzanowska D (2014) Candidaemia in a Polish tertiary paediatric hospital, 2000 to 2010. Mycoses 57(2):105–109PubMedCrossRefGoogle Scholar
  33. 33.
    Ericsson J, Chryssanthou E, Klingspor L, Johansson AG, Ljungman P, Svensson E, Sjölin J (2013) Candidaemia in Sweden: a nationwide prospective observational survey. Clin Microbiol Infect 19(4):E218–E221PubMedCrossRefGoogle Scholar
  34. 34.
    Fochtmann A, Forstner C, Hagmann M, Keck M, Muschitz G, Presterl E, Ihra G, Rath T (2015) Predisposing factors for candidemia in patients with major burns. Burns 41(2):326–332PubMedCrossRefGoogle Scholar
  35. 35.
    Fortún J, Martín-Dávila P, Gómez-García de la Pedrosa E, Pintado V, Cobo J, Fresco G, Meije Y, Ros L, Alvarez ME, Luengo J, Agundez M, Belso A, Sánchez-Sousa A, Loza E, Moreno S (2012) Emerging trends in candidemia: a higher incidence but a similar outcome. J Infect 65(1):64–70PubMedCrossRefGoogle Scholar
  36. 36.
    Gamaletsou MN, Walsh TJ, Zaoutis T, Pagoni M, Kotsopoulou M, Voulgarelis M, Panayiotidis P, Vassilakopoulos T, Angelopoulou MK, Marangos M, Spyridonidis A, Kofteridis D, Pouli A, Sotiropoulos D, Matsouka P, Argyropoulou A, Perloretzou S, Leckerman K, Manaka A, Oikonomopoulos P, Daikos G, Petrikkos G, Sipsas NV (2014) A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies. Clin Microbiol Infect 20(1):O50–O57PubMedCrossRefGoogle Scholar
  37. 37.
    Garnacho-Montero J, Díaz-Martín A, García-Cabrera E, Ruiz Pérez de Pipaón M, Hernández-Caballero C, Aznar-Martín J, Cisneros JM, Ortiz-Leyba C (2010) Risk factors for fluconazole-resistant candidemia. Antimicrob Agents Chemother 54(8):3149–3154PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Karadag-Oncel E, Kara A, Ozsurekci Y, Arikan-Akdagli S, Cengiz AB, Ceyhan M, Gur D, Celik M, Ozkaya-Parlakay A (2015) Candidaemia in a paediatric centre and importance of central venous catheter removal. Mycoses 58(3):140–148PubMedCrossRefGoogle Scholar
  39. 39.
    Klingspor L, Tortorano AM, Peman J, Willinger B, Hamal P, Sendid B, Velegraki A, Kibbler C, Meis JF, Sabino R, Ruhnke M, Arikan-Akdagli S, Salonen J, Dóczi I (2015) Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006-2008). Clin Microbiol Infect 21(1):87.e1–87.e10Google Scholar
  40. 40.
    Leroy O, Mira JP, Montravers P, Gangneux JP, Lortholary O, AmarCand Study Group (2010) Comparison of albicans vs. non-albicans candidemia in French intensive care units. Crit Care 14(3):R98PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Lortholary O, Renaudat C, Sitbon K, Madec Y, Denoeud-Ndam L, Wolff M, Fontanet A, Bretagne S, Dromer F, French Mycosis Study Group (2014) Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010). Intensive Care Med 40(9):1303–1312PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Meyer E, Geffers C, Gastmeier P, Schwab F (2013) No increase in primary nosocomial candidemia in 682 German intensive care units during 2006 to 2011. Euro Surveill. 18(24). pii: 20505Google Scholar
  43. 43.
    Parmeland L, Gazon M, Guerin C, Argaud L, Lehot JJ, Bastien O, Allaouchiche B, Michallet M, Picot S, Bienvenu AL, Study Group (2013) Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade. Med Mycol 51(1):33–37Google Scholar
  44. 44.
    Pongrácz J, Juhász E, Iván M, Kristóf K (2015) Significance of yeasts in bloodstream infection: epidemiology and predisposing factors of Candidaemia in adult patients at a university hospital (2010-2014). Acta Microbiol Immunol Hung 62(3):317–329PubMedCrossRefGoogle Scholar
  45. 45.
    Puig-Asensio M, Ruiz-Camps I, Fernández-Ruiz M, Aguado JM, Muñoz P, Valerio M, Delgado-Iribarren A, Merino P, Bereciartua E, Fortún J, Cuenca-Estrella M, Almirante B, CANDIPOP Project, GEIH-GEMICOMED (SEIMC), and REIPI (2015) Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain. Clin Microbiol Infect 21(5):491.e1–491.e10Google Scholar
  46. 46.
    Ruhnke M, Paiva JA, Meersseman W, Pachl J, Grigoras I, Sganga G, Menichetti F, Montravers P, Auzinger G, Dimopoulos G, Borges Sá M, Miller PJ, Marček T, Kantecki M (2012) Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients. Clin Microbiol Infect 18(7):680–687PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Tortorano AM, Prigitano A, Lazzarini C, Passera M, Deiana ML, Cavinato S, De Luca C, Grancini A, Lo Cascio G, Ossi C, Sala E, Montagna MT (2013) A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade. Infection 41(3):655–662PubMedCrossRefGoogle Scholar
  48. 48.
    Tragiannidis A, Fegeler W, Rellensmann G, Debus V, Müller V, Hoernig-Franz I, Siam K, Pana ZD, Jürgens H, Groll AH (2012) Candidaemia in a European Paediatric University Hospital: a 10-year observational study. Clin Microbiol Infect 18(2):E27–E30PubMedCrossRefGoogle Scholar
  49. 49.
    Tumbarello M, Fiori B, Trecarichi EM, Posteraro P, Losito AR, De Luca A, Sanguinetti M, Fadda G, Cauda R, Posteraro B (2012) Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital. PLoS One 7(3):e33705PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Ylipalosaari P, Ala-Kokko TI, Karhu J, Koskela M, Laurila J, Ohtonen P, Syrjälä H (2012) Comparison of the epidemiology, risk factors, outcome and degree of organ failures of patients with candidemia acquired before or during ICU treatment. Crit Care 16(2):R62PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Zirkel J, Klinker H, Kuhn A, Abele-Horn M, Tappe D, Turnwald D, Einsele H, Heinz WJ (2012) Epidemiology of Candida blood stream infections in patients with hematological malignancies or solid tumors. Med Mycol 50(1):50–55Google Scholar
  52. 52.
    Al-Rawahi GN, Roscoe DL (2013) Ten-year review of candidemia in a Canadian tertiary care centre: predominance of non-albicans Candida species. Can J Infect Dis Med Microbiol 24(3):e65–e68Google Scholar
  53. 53.
    Benjamin DK Jr, Stoll BJ, Gantz MG, Walsh MC, Sánchez PJ, Das A, Shankaran S, Higgins RD, Auten KJ, Miller NA, Walsh TJ, Laptook AR, Carlo WA, Kennedy KA, Finer NN, Duara S, Schibler K, Chapman RL, Van Meurs KP, Frantz ID 3rd, Phelps DL, Poindexter BB, Bell EF, O’Shea TM, Watterberg KL, Goldberg RN, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network (2010) Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics 126(4):e865–e873PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Chitnis AS, Magill SS, Edwards JR, Chiller TM, Fridkin SK, Lessa FC (2012) Trends in Candida central line-associated bloodstream infections among NICUs, 1999-2009. Pediatrics 130(1):e46–e52Google Scholar
  55. 55.
    Cleveland AA, Farley MM, Harrison LH, Stein B, Hollick R, Lockhart SR, Magill SS, Derado G, Park BJ, Chiller TM (2012) Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis 55(10):1352–1361PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Corzo-León DE, Satlin MJ, Soave R, Shore TB, Schuetz AN, Jacobs SE, Walsh TJ (2015) Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens. Mycoses 58(6):325–336PubMedCrossRefGoogle Scholar
  57. 57.
    Diekema D, Arbefeville S, Boyken L, Kroeger J, Pfaller M (2012) The changing epidemiology of healthcare-associated candidemia over three decades. Diagn Microbiol Infect Dis 73(1):45–48PubMedCrossRefGoogle Scholar
  58. 58.
    Dotis J, Prasad PA, Zaoutis T, Roilides E (2012) Epidemiology, risk factors and outcome of Candida parapsilosis bloodstream infection in children. Pediatr Infect Dis J 31(6):557–560Google Scholar
  59. 59.
    Festekjian A, Neely M (2011) Incidence and predictors of invasive candidiasis associated with candidaemia in children. Mycoses 54(2):146–153PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Guzman JA, Tchokonte R, Sobel JD (2011) Septic shock due to candidemia: outcomes and predictors of shock development. J Clin Med Res 3(2):65–71PubMedPubMedCentralGoogle Scholar
  61. 61.
    Kollef M, Micek S, Hampton N, Doherty JA, Kumar A (2012) Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis 54(12):1739–1746Google Scholar
  62. 62.
    Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden CB, Baughman W, Stein B, Hollick R, Park BJ, Chiller T (2012) Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol 50(11):3435–3442Google Scholar
  63. 63.
    Matsumoto E, Boyken L, Tendolkar S, McDanel J, Castanheira M, Pfaller M, Diekema D (2014) Candidemia surveillance in Iowa: emergence of echinocandin resistance. Diagn Microbiol Infect Dis 79(2):205–208PubMedCrossRefGoogle Scholar
  64. 64.
    Pfaller M, Neofytos D, Diekema D, Azie N, Meier-Kriesche HU, Quan SP, Horn D (2012) Epidemiology and outcomes of candidemia in 3648 patients: data from the prospective antifungal therapy (PATH Alliance®) registry, 2004-2008. Diagn Microbiol Infect Dis 74(4):323–331PubMedCrossRefGoogle Scholar
  65. 65.
    Reno J, Doshi S, Tunali AK, Stein B, Farley MM, Ray SM, Jacob JT (2015) Epidemiology of Methicillin-resistant staphylococcus aureus bloodstream coinfection among adults with candidemia in Atlanta, GA, 2008-2012. Infect Control Hosp Epidemiol 36(11):1298–1304PubMedCrossRefGoogle Scholar
  66. 66.
    Robinson JA, Pham HD, Bloom BT, Wittler RR (2012) Risk factors for persistent candidemia infection in a neonatal intensive care unit and its effect on mortality and length of hospitalization. J Perinatol 32(8):621–625PubMedCrossRefGoogle Scholar
  67. 67.
    Vallabhaneni S, Almendares O, Farley MM, Reno J, Smith ZT, Stein B, Magill SS, Smith RM, Cleveland AA, Lessa FC (2015) Epidemiology and factors associated with candidaemia following Clostridium difficile infection in adults within metropolitan Atlanta, 2009-2013. Epidemiol Infect 26:1–5 [Epub ahead of print]Google Scholar
  68. 68.
    Wang E, Farmakiotis D, Yang D, McCue DA, Kantarjian HM, Kontoyiannis DP, Mathisen MS (2015) The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality. J Antimicrob Chemother 70(8):2362–2368PubMedCrossRefGoogle Scholar
  69. 69.
    Wisplinghoff H, Ebbers J, Geurtz L, Stefanik D, Major Y, Edmond MB, Wenzel RP, Seifert H (2014) Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents 43(1):78–81Google Scholar
  70. 70.
    Bustamante B, Martins MA, Bonfietti LX, Szeszs MW, Jacobs J, Garcia C, Melhem MS (2014) Species distribution and antifungal susceptibility profile of Candida isolates from bloodstream infections in Lima. Peru J Med Microbiol 63(Pt 6):855–860Google Scholar
  71. 71.
    Colombo AL, Guimarães T, Sukienik T, Pasqualotto AC, Andreotti R, Queiroz-Telles F, Nouér SA, Nucci M (2014) Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period. Intensive Care Med 40(10):1489–1498PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Cortés JA, Reyes P, Gómez CH, Cuervo SI, Rivas P, Casas CA, Sánchez R (2014) Clinical and epidemiological characteristics and risk factors for mortality in patients with candidemia in hospitals from Bogotá. Colombia Braz J Infect Dis 18(6):631–637PubMedCrossRefGoogle Scholar
  73. 73.
    da Costa VG, Quesada RM, Abe AT, Furlaneto-Maia L, Furlaneto MC (2014) Nosocomial bloodstream Candida infections in a tertiary-care hospital in South Brazil: a 4-year survey. Mycopathologia 178(3–4):243–250Google Scholar
  74. 74.
    Guimarães T, Nucci M, Mendonça JS, Martinez R, Brito LR, Silva N, Moretti ML, Salomão R, Colombo AL (2012) Epidemiology and predictors of a poor outcome in elderly patients with candidemia. Int J Infect Dis 16(6):e442–e447PubMedCrossRefGoogle Scholar
  75. 75.
    Hoffmann-Santos HD, Paula CR, Yamamoto AC, Tadano T, Hahn RC (2013) Six-year trend analysis of nosocomial candidemia and risk factors in two intensive care hospitals in Mato Grosso, midwest region of Brazil. Mycopathologia 176(5–6):409–415PubMedCrossRefGoogle Scholar
  76. 76.
    Moretti ML, Trabasso P, Lyra L, Fagnani R, Resende MR, de Oliveira Cardoso LG, Schreiber AZ (2013) Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil. Med Mycol 51(3):225–230Google Scholar
  77. 77.
    Nucci M, Queiroz-Telles F, Alvarado-Matute T, Tiraboschi IN, Cortes J, Zurita J, Guzman-Blanco M, Santolaya ME, Thompson L, Sifuentes-Osornio J, Echevarria JI, Colombo AL, Latin American Invasive Mycosis Network (2013) Epidemiology of candidemia in Latin America: a laboratory-based survey. PLoS One 8(3):e59373PubMedPubMedCentralCrossRefGoogle Scholar
  78. 78.
    Oliveira VK, Ruiz Lda S, Oliveira NA, Moreira D, Hahn RC, Melo AS, Nishikaku AS, Paula CR (2014) Fungemia caused by Candida species in a children’s public hospital in the city of São Paulo, Brazil: study in the period 2007-2010. Rev Inst Med Trop Sao Paulo 56(4):301–305Google Scholar
  79. 79.
    Wille MP, Guimarães T, Furtado GH, Colombo AL (2013) Historical trends in the epidemiology of candidaemia: analysis of an 11-year period in a tertiary care hospital in Brazil. Mem Inst Oswaldo Cruz 108(3). pii: S0074-02762013000300288Google Scholar
  80. 80.
    Al Thaqafi AH, Farahat FM, Al Harbi MI, Al Amri AF, Perfect JR (2014) Predictors and outcomes of Candida bloodstream infection: eight-year surveillance, western Saudi Arabia. Int J Infect Dis 21:5–9Google Scholar
  81. 81.
    Chakrabarti A, Sood P, Rudramurthy SM, Chen S, Kaur H, Capoor M, Chhina D, Rao R, Eshwara VK, Xess I, Kindo AJ, Umabala P, Savio J, Patel A, Ray U, Mohan S, Iyer R, Chander J, Arora A, Sardana R, Roy I, Appalaraju B, Sharma A, Shetty A, Khanna N, Marak R, Biswas S, Das S, Harish BN, Joshi S, Mendiratta D (2015) Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med 41(2):285–295PubMedCrossRefGoogle Scholar
  82. 82.
    Chander J, Singla N, Sidhu SK, Gombar S (2013) Epidemiology of Candida blood stream infections: experience of a tertiary care centre in North India. J Infect Dev Ctries 7(9):670–675Google Scholar
  83. 83.
    Chang TP, Ho MW, Yang YL, Lo PC, Lin PS, Wang AH, Lo HJ (2013) Distribution and drug susceptibilities of Candida species causing candidemia from a medical center in central Taiwan. J Infect Chemother 19(6):1065–1071Google Scholar
  84. 84.
    Chen PY, Chuang YC, Wang JT, Sheng WH, Yu CJ, Chu CC, Hsueh PR, Chang SC, Chen YC (2014) Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010. J Microbiol Immunol Infect 47(2):95–103PubMedCrossRefGoogle Scholar
  85. 85.
    Farooqi JQ, Jabeen K, Saeed N, Iqbal N, Malik B, Lockhart SR, Zafar A, Brandt ME, Hasan R (2013) Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility. J Med Microbiol 62(Pt 2):259–268PubMedCrossRefGoogle Scholar
  86. 86.
    Han SS, Yim JJ, Yoo CG, Kim YW, Han SK, Shim YS, Lee SM (2010) Clinical characteristics and risk factors for nosocomial candidemia in medical intensive care units: experience in a single hospital in Korea for 6.6 years. J Korean Med Sci 25(5):671–676PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Hii IM, Chang HL, Lin LC, Lee YL, Liu YM, Liu CE, Chen CH, Cheng YR, Chang CY (2015) Changing epidemiology of candidemia in a medical center in middle Taiwan. J Microbiol Immunol Infect 48(3):306–315PubMedCrossRefGoogle Scholar
  88. 88.
    Hirano R, Sakamoto Y, Kudo K, Ohnishi M (2015) Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: a single hospital experience. Infect Drug Resist 8:199–205Google Scholar
  89. 89.
    Huang YT, Liu CY, Liao CH, Chung KP, Sheng WH, Hsueh PR (2014) Antifungal susceptibilities of Candida isolates causing bloodstream infections at a medical center in Taiwan, 2009-2010. Antimicrob Agents Chemother 58(7):3814–3819Google Scholar
  90. 90.
    Kim HK, Park YK, Wang HJ, Kim BW, Shin SY, Lim SK, Choi YH (2013) Epidemiology and clinical features of post-transplant bloodstream infection: an analysis of 222 consecutive liver transplant recipients. Infect Chemother 45(3):315–324PubMedPubMedCentralCrossRefGoogle Scholar
  91. 91.
    Kumar S, Kalam K, Ali S, Siddiqi S, Baqi S (2014) Frequency, clinical presentation and microbiological spectrum of candidaemia in a tertiary care center in Karachi. Pakistan J Pak Med Assoc 64(3):281–285PubMedGoogle Scholar
  92. 92.
    Li D, Zhang W, Zheng S, Ma Z, Zhang P, Liu Z (2013) Surveillance study of candidemia in cancer patients in North China. Med Mycol 51(4):378–384PubMedCrossRefGoogle Scholar
  93. 93.
    Liu WL, Lin HL, Lai CC (2014) Different epidemiology of candidemia in intensive care unit patients at a hospital in Taiwan. J Postgrad Med 60(1):88–89PubMedGoogle Scholar
  94. 94.
    Pu S, Niu S, Zhang C, Xu X, Qin M, Huang S, Zhang L (2015) Epidemiology, antifungal susceptibilities, and risk factors for invasive candidiasis from 2011 to 2013 in a teaching hospital in southwest China. J Microbiol Immunol Infect. pii: S1684-1182(15)00029-8. doi:  10.1016/j.jmii.2015.01.005. [Epub ahead of print]
  95. 95.
    Tak V, Mathur P, Varghese P, Gunjiyal J, Xess I, Misra MC (2014) The epidemiological profile of candidemia at an Indian trauma care center. J Lab Physicians 6(2):96–101PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    Tan BH, Chakrabarti A, Li RY, Patel AK, Watcharananan SP, Liu Z, Chindamporn A, Tan AL, Sun PL, Wu UI, Chen YC, Asia Fungal Working Group (AFWG); Asia Fungal Working Group AFWG (2015) Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study. Clin Microbiol Infect 21(10):946–953. doi: 10.1016/j.cmi.2015.06.010, Epub 2015 Jun 20PubMedCrossRefGoogle Scholar
  97. 97.
    Tang HJ, Liu WL, Lin HL, Lai CC (2015) Epidemiology and prognostic factors of candidemia in elderly patients. Geriatr Gerontol Int 15(6):688–693PubMedCrossRefGoogle Scholar
  98. 98.
    Wang H, Liu N, Yin M, Han H, Yue J, Zhang F, Shan T, Guo H, Wu D (2014) The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study. BMC Infect Dis 14:609PubMedPubMedCentralCrossRefGoogle Scholar
  99. 99.
    Wu Z, Liu Y, Feng X, Liu Y, Wang S, Zhu X, Chen Q, Pan S (2014) Candidemia: incidence rates, type of species, and risk factors at a tertiary care academic hospital in China. Int J Infect Dis 22:4–8PubMedCrossRefGoogle Scholar
  100. 100.
    Xia H, Wu H, Xia S, Zhu X, Chen C, Qiu G, Zhou W, Shi Y, Ma L, Sun J, Zhou X, Zhu J (2014) Invasive Candidiasis in preterm neonates in China: a retrospective study from 11 NICUS during 2009-2011. Pediatr Infect Dis J 33(1):106–109PubMedCrossRefGoogle Scholar
  101. 101.
    Yang ZT, Wu L, Liu XY, Zhou M, Li J, Wu JY, Cai Y, Mao EQ, Chen EZ, Lortholary O (2014) Epidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in Shanghai. BMC Infect Dis 14:241Google Scholar
  102. 102.
    Zhang XB, Yu SJ, Yu JX, Gong YL, Feng W, Sun FJ (2012) Retrospective analysis of epidemiology and prognostic factors for candidemia at a hospital in China, 2000-2009. Jpn J Infect Dis 65(6):510–515PubMedCrossRefGoogle Scholar
  103. 103.
    Hegazi M, Abdelkader A, Zaki M, El-Deek B (2014) Characteristics and risk factors of candidemia in pediatric intensive care unit of a tertiary care children’s hospital in Egypt. J Infect Dev Ctries 8(5):624–634PubMedCrossRefGoogle Scholar
  104. 104.
    Kreusch A, Karstaedt AS (2013) Candidemia among adults in Soweto, South Africa, 1990-2007. Int J Infect Dis 17(8):e621–e623PubMedCrossRefGoogle Scholar
  105. 105.
    Health Protection Agency (HPA) (2006) Fungal diseases in the UK: the current provision of support for diagnosis and treatment: assessment and proposed network solution. Report of a working group of the HPA Advisory Committee for Fungal Infection and Superficial Parasites. Health Protection Agency, London. (http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1196942156347)
  106. 106.
    Eggimann P, Garbino J, Pittet D (2003) Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 3(11):685–702Google Scholar
  107. 107.
    Guery BP, Arendrup MC, Auzinger G, Azoulay E, Borges Sá M, Johnson EM, Müller E, Putensen C, Rotstein C, Sganga G, Venditti M, Zaragoza Crespo R, Kullberg BJ (2009) Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis. Intensive Care Med 35(1):55–62PubMedCrossRefGoogle Scholar
  108. 108.
    Muskett H, Shahin J, Eyres G, Harvey S, Rowan K, Harrison D (2011) Risk factors for invasive fungal disease in critically ill adult patients: a systematic review. Crit Care 15(6):R287PubMedPubMedCentralCrossRefGoogle Scholar
  109. 109.
    Johnson MD, Plantinga TS, van de Vosse E, Velez Edwards DR, Smith PB, Alexander BD, Yang JC, Kremer D, Laird GM, Oosting M, Joosten LA, van der Meer JW, van Dissel JT, Walsh TJ, Perfect JR, Kullberg BJ, Scott WK, Netea MG (2012) Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study. Clin Infect Dis 54(4):502–510PubMedCrossRefGoogle Scholar
  110. 110.
    Plantinga TS, Johnson MD, Scott WK, van de Vosse E, Velez Edwards DR, Smith PB, Alexander BD, Yang JC, Kremer D, Laird GM, Oosting M, Joosten LA, van der Meer JW, van Dissel JT, Walsh TJ, Perfect JR, Kullberg BJ, Netea MG (2012) Toll-like receptor 1 polymorphisms increase susceptibility to candidemia. J Infect Dis 205(6):934–943PubMedPubMedCentralCrossRefGoogle Scholar
  111. 111.
    Lionakis MS, Netea MG (2013) Candida and host determinants of susceptibility to invasive candidiasis. PLoS Pathog 9(1):e1003079PubMedPubMedCentralCrossRefGoogle Scholar
  112. 112.
    Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C (2005) The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 41(9):1232–1239PubMedCrossRefGoogle Scholar
  113. 113.
    Reboli AC, Shorr AF, Rotstein C, Pappas PG, Kett DH, Schlamm HT, Reisman AL, Biswas P, Walsh TJ (2011) Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome. BMC Infect Dis 11:261Google Scholar
  114. 114.
    Alexander BD, Johnson MD, Pfeiffer CD, Jiménez-Ortigosa C, Catania J, Booker R, Castanheira M, Messer SA, Perlin DS, Pfaller MA (2013) Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 56(12):1724–1732Google Scholar
  115. 115.
    Forastiero A, Garcia-Gil V, Rivero-Menendez O, Garcia-Rubio R, Monteiro MC, Alastruey-Izquierdo A, Jordan R, Agorio I, Mellado E (2015) Rapid development of Candida krusei echinocandin resistance during caspofungin therapy. Antimicrob Agents Chemother 59(11):6975–6982Google Scholar
  116. 116.
    Fekkar A, Dannaoui E, Meyer I, Imbert S, Brossas JY, Uzunov M, Mellon G, Nguyen S, Guiller E, Caumes E, Leblond V, Mazier D, Fievet MH, Datry A (2014) Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy? Eur J Clin Microbiol Infect Dis 33(9):1489–1496Google Scholar
  117. 117.
    Lanjewar DN (2011) The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of 236 autopsied cases in Mumbai, India. Pathol Res Int 2011:547618CrossRefGoogle Scholar
  118. 118.
    True DG, Penmetcha M, Peckham SJ (2002) Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab. J Rheumatol 29(7):1561–1563PubMedGoogle Scholar
  119. 119.
    Bassetti M, Repetto E, Mikulska M, Miglino M, Clavio M, Gobbi M, Righi E, Viscoli C (2009) Cryptococcus neoformans fatal sepsis in a chronic lymphocytic leukemia patient treated with alemtuzumab: case report and review of the literature. J Chemother 21(2):211–214Google Scholar
  120. 120.
    Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23(4):525–530PubMedCrossRefGoogle Scholar
  121. 121.
    Scarborough M, Gordon SB, Whitty CJ, French N, Njalale Y, Chitani A, Peto TE, Lalloo DG, Zijlstra EE (2007) Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med 357(24):2441–2450PubMedPubMedCentralCrossRefGoogle Scholar
  122. 122.
    Calvo BM, Colombo AL, Fischman O, Santiago A, Thompson L, Lazera M, Telles F, Fukushima K, Nishimura K, Tanaka R, Myiajy M, Moretti-Branchini ML (2001) Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela. J Clin Microbiol 39(6):2348–2350PubMedPubMedCentralCrossRefGoogle Scholar
  123. 123.
    Byrnes EJ 3rd, Bildfell RJ, Frank SA, Mitchell TG, Marr KA, Heitman J (2009) Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States. J Infect Dis 199(7):1081–1086Google Scholar
  124. 124.
    Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, Fyfe M, Macdougall L, Boekhout T, Kwon-Chung KJ, Meyer W (2004) A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A 101(49):17258–17263Google Scholar
  125. 125.
    Colom MF, Frasés S, Ferrer C, Jover A, Andreu M, Reus S, Sánchez M, Torres-Rodríguez JM (2005) First case of human cryptococcosis due to Cryptococcus neoformans var. gattii in Spain. J Clin Microbiol 43(7):3548–3550Google Scholar
  126. 126.
    Hagen F, Colom MF, Swinne D, Tintelnot K, Iatta R, Montagna MT, Torres-Rodriguez JM, Cogliati M, Velegraki A, Burggraaf A, Kamermans A, Sweere JM, Meis JF, Klaassen CH, Boekhout T (2012) Autochthonous and dormant Cryptococcus gattii infections in Europe. Emerg Infect Dis 18(10):1618–1624Google Scholar
  127. 127.
    Cheng MF, Chiou CC, Liu YC, Wang HZ, Hsieh KS (2001) Cryptococcus laurentii fungemia in a premature neonate. J Clin Microbiol 39(4):1608–1611Google Scholar
  128. 128.
    Khawcharoenporn T, Apisarnthanarak A, Kiratisin P, Mundy LM, Bailey TC (2006) Evaluation of Cryptococcus laurentii meningitis in a patient with HIV infection: a case report and review of the literature. Hawaii Med J 65(9):260–263Google Scholar
  129. 129.
    Chen SC, Meyer W, Sorrell TC (2014) Cryptococcus gattii infections. Clin Microbiol Rev 27(4):980–1024Google Scholar
  130. 130.
    Cogliati M (2013) Global molecular epidemiology of cryptococcus neoformans and Cryptococcus gattii: an Atlas of the molecular types. Scientifica (Cairo). 2013:675213Google Scholar
  131. 131.
    Lass-Flörl C (2016) Current challenges in the diagnosis of fungal infections. In: Lion T (ed.) Human fungal pathogen identification: Methods and protocols. Methods molecular biology. Humana Press, New YorkGoogle Scholar
  132. 132.
    Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34:7e14Google Scholar
  133. 133.
    De Pauw B, Walsh T, Donnelly J et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821PubMedPubMedCentralCrossRefGoogle Scholar
  134. 134.
    Tsitsikas DA, Morin A, Araf S, Murtagh B, Johnson G, Vinnicombe S, Ellis S, Suaris T, Wilks M, Doffman S, Agrawal SG (2012) Impact of the revised (2008) EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis. Med Mycol 50(5):538–542PubMedCrossRefGoogle Scholar
  135. 135.
    Dasbach EJ, Davies GM, Teutsch SM (2000) Burden of aspergillosis-related hospitalizations in the United States. Clin Infect Dis 31(6):1524–1528PubMedCrossRefGoogle Scholar
  136. 136.
    Lewis RE, Cahyame-Zuniga L, Leventakos K, Chamilos G, Ben-Ami R, Tamboli P, Tarrand J, Bodey GP, Luna M, Kontoyiannis DP (2013) Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses 56(6):638–645PubMedCrossRefGoogle Scholar
  137. 137.
    Bergeron A, Porcher R, Sulahian A, de Bazelaire C, Chagnon K, Raffoux E, Vekhoff A, Cornet M, Isnard F, Brethon B, Lacroix C, Poirot JL, Bouges C, Derouin F, Tazi A, Ribaud P (2012) The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. Blood 119(8):1831–1837, quiz 1956PubMedCrossRefGoogle Scholar
  138. 138.
    Domenech C, Leick-Courtois C, Bienvenu AL, Pracros JP, Picot S, Bleyzac N, Bertrand Y (2015) Improvement in the outcome of invasive aspergillosis in a pediatric hematology department: a 10-year review. J Pediatr Hematol Oncol 37(7):560–565PubMedCrossRefGoogle Scholar
  139. 139.
    Gheith S, Saghrouni F, Bannour W, Ben Youssef Y, Khelif A, Normand AC, Ben Said M, Piarroux R, Njah M, Ranque S (2014) Characteristics of invasive aspergillosis in neutropenic haematology patients (Sousse, Tunisia). Mycopathologia 177(5–6):281–289PubMedCrossRefGoogle Scholar
  140. 140.
    Kurosawa M, Yonezumi M, Hashino S, Tanaka J, Nishio M, Kaneda M, Ota S, Koda K, Suzuki N, Yoshida M, Hirayama Y, Takimoto R, Torimoto Y, Mori A, Takahashi T, Iizuka S, Ishida T, Kobayashi R, Oda T, Sakai H, Yamamoto S, Takahashi F, Fukuhara T (2012) Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol 96(6):748–757PubMedCrossRefGoogle Scholar
  141. 141.
    Michallet M, Bénet T, Sobh M, Kraghel S, El Hamri M, Cannas G, Nicolini FE, Labussière H, Ducastelle S, Barraco F, Thomas X, Chelghoum Y, Nicolle MC, Bienvenu AL, Persat F, De Monbrison F, Picot S, Vanhems P (2012) Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients. Eur J Clin Microbiol Infect Dis 31(6):991–997PubMedCrossRefGoogle Scholar
  142. 142.
    Montagna MT, De Giglio O, Napoli C, Lovero G, Caggiano G, Delia M, Pastore D, Santoro N, Specchia G (2012) Invasive fungal infections in patients with hematologic malignancies (aurora project): lights and shadows during 18-months surveillance. Int J Mol Sci 13(1):774–787PubMedPubMedCentralCrossRefGoogle Scholar
  143. 143.
    Racil Z, Weinbergerova B, Kocmanova I, Muzik J, Kouba M, Drgona L, Masarova L, Guman T, Tothova E, Forsterova K, Haber J, Ziakova B, Bojtarova E, Vydra J, Mudry P, Foralova R, Sejnova D, Mallatova N, Kandrnal V, Cetkovsky P, Mayer J (2013) Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: fungal infection database (FIND) analysis, 2005-2009. Int J Infect Dis 17(2):e101–e109PubMedCrossRefGoogle Scholar
  144. 144.
    Nucci M, Garnica M, Gloria AB, Lehugeur DS, Dias VC, Palma LC, Cappellano P, Fertrin KY, Carlesse F, Simões B, Bergamasco MD, Cunha CA, Seber A, Ribeiro MP, Queiroz-Telles F, Lee ML, Chauffaille ML, Silla L, de Souza CA, Colombo AL (2013) Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil. Clin Microbiol Infect 19(8):745–751PubMedCrossRefGoogle Scholar
  145. 145.
    Herbrecht R, Caillot D, Cordonnier C, Auvrignon A, Thiébaut A, Brethon B, Michallet M, Mahlaoui N, Bertrand Y, Preziosi P, Ruiz F, Gorin NC, Gangneux JP (2012) Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation. J Antimicrob Chemother 67(11):2731–2738PubMedCrossRefGoogle Scholar
  146. 146.
    Atalla A, Garnica M, Maiolino A, Nucci M (2015) Risk factors for invasive mould diseases in allogeneic hematopoietic cell transplant recipients. Transpl Infect Dis 17(1):7–13Google Scholar
  147. 147.
    Hol JA, Wolfs TF, Bierings MB, Lindemans CA, Versluys AB, de Wildt A, Gerhardt CE, Boelens JJ (2014) Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients. Bone Marrow Transplant 49(1):95–101PubMedCrossRefGoogle Scholar
  148. 148.
    Parody R, Martino R, de la Cámara R, García-Noblejas A, Esquirol A, Garcia-Cadenas I, Villaescusa T, Caballero D, Rovira M, Fernandez-Avilés F, Marquez-Malaver FJ, Espigado I, Castilla-Llorente C, Heras I, Cabero MA, Cabrera JR, Barba P, Valcarcel D, Sánchez-Ortega I, Duarte RF, Serrano D, Carretero F, Vazquez L (2015) Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time. Bone Marrow Transplant 50(2):274–281PubMedCrossRefGoogle Scholar
  149. 149.
    Salmeron G, Porcher R, Bergeron A, Robin M, Peffault de Latour R, Ferry C, Rocha V, Petropoulou A, Xhaard A, Lacroix C, Sulahian A, Socié G, Ribaud P (2012) Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis. Haematologica 97(9):1357–1363PubMedPubMedCentralCrossRefGoogle Scholar
  150. 150.
    Choi SH, Kang ES, Eo H, Yoo SY, Kim JH, Yoo KH, Sung KW, Koo HH, Kim YJ (2013) Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients. Pediatr Blood Cancer 60(2):316–322Google Scholar
  151. 151.
    Han SB, Kim SK, Bae EY, Lee JW, Yoon JS, Chung NG, Cho B, Jeong DC, Kang JH, Kim HK, Lee DG, Lee HS, Im SA (2015) Clinical features and prognosis of invasive pulmonary aspergillosis in Korean children with hematologic/oncologic diseases. J Korean Med Sci 30(8):1121–1128PubMedPubMedCentralCrossRefGoogle Scholar
  152. 152.
    Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K (2009) Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of multicenter prospective antifungal therapy (PATH) alliance registry. Clin Infect Dis 48(3):265–273PubMedCrossRefGoogle Scholar
  153. 153.
    Muñoz P, Cerón I, Valerio M, Palomo J, Villa A, Eworo A, Fernández-Yáñez J, Guinea J, Bouza E (2014) Invasive aspergillosis among heart transplant recipients: a 24-year perspective. J Heart Lung Transplant 33(3):278–288PubMedCrossRefGoogle Scholar
  154. 154.
    Pérez-Sáez MJ, Mir M, Montero MM, Crespo M, Montero N, Gómez J, Horcajada JP, Pascual J (2014) Invasive aspergillosis in kidney transplant recipients: a cohort study. Exp Clin Transplant 12(2):101–105PubMedGoogle Scholar
  155. 155.
    Santos T, Aguiar B, Santos L, Romaozinho C, Tome R, Macario F, Alves R, Campos M, Mota A (2015) Invasive fungal infections after kidney transplantation: a single-center experience. Transplant Proc 47(4):971–975PubMedCrossRefGoogle Scholar
  156. 156.
    Ok Atılgan A, Özdemir BH, Kırnap M, Akdur A, Yılmaz Akçay E, Akar Özkan E, Haberal M (2014) Invasive fungal infections in liver transplant recipients. Exp Clin Transplant 12(Suppl 1):110–116PubMedGoogle Scholar
  157. 157.
    Qin J, Fang Y, Dong Y, Zhu K, Wu B, An Y, Shan H (2012) Radiological and clinical findings of 25 patients with invasive pulmonary aspergillosis: retrospective analysis of 2150 liver transplantation cases. Br J Radiol 85(1016):e429–e435PubMedPubMedCentralCrossRefGoogle Scholar
  158. 158.
    Sganga G, Bianco G, Frongillo F, Lirosi MC, Nure E, Agnes S (2014) Fungal infections after liver transplantation: incidence and outcome. Transplant Proc 46(7):2314–2318PubMedCrossRefGoogle Scholar
  159. 159.
    Chong PP, Kennedy CC, Hathcock MA, Kremers WK, Razonable RR (2015) Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis. Clin Transplant 29(4):311–318PubMedCrossRefGoogle Scholar
  160. 160.
    Peghin M, Monforte V, Martin-Gomez MT, Ruiz-Camps I, Berastegui C, Saez B, Riera J, Ussetti P, Solé J, Gavaldá J, Roman A (2015) 10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation. Transpl IntGoogle Scholar
  161. 161.
    Tofte N, Jensen C, Tvede M, Andersen CB, Carlsen J, Iversen M (2012) Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients. Scand J Infect Dis 44(11):835–841Google Scholar
  162. 162.
    Bodro M, Sabé N, Gomila A, Ayats J, Baliellas C, Roca J, Melilli E, Carratalà J (2012) Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients. Transplant Proc 44(9):2682–2685PubMedCrossRefGoogle Scholar
  163. 163.
    Hoyo I, Sanclemente G, de la Bellacasa JP, Cofán F, Ricart MJ, Cardona M, Colmenero J, Fernández J, Escorsell A, Navasa M, Moreno A, Cervera C (2014) Epidemiology, clinical characteristics, and outcome of invasive aspergillosis in renal transplant patients. Transpl Infect Dis 16(6):951–957PubMedCrossRefGoogle Scholar
  164. 164.
    Hedayati MT, Khodavaisy S, Alialy M, Omran SM, Habibi MR (2013) Invasive aspergillosis in intensive care unit patients in Iran. Acta Medica (Hradec Kralove) 56(2):52–56CrossRefGoogle Scholar
  165. 165.
    Montagna MT, Caggiano G, Lovero G, De Giglio O, Coretti C, Cuna T, Iatta R, Giglio M, Dalfino L, Bruno F, Puntillo F (2013) Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA project). Infection 41(3):645–653PubMedPubMedCentralCrossRefGoogle Scholar
  166. 166.
    Taccone FS, Van den Abeele AM, Bulpa P, Misset B, Meersseman W, Cardoso T, Paiva JA, Blasco-Navalpotro M, De Laere E, Dimopoulos G, Rello J, Vogelaers D, Blot S, AspICU Study Investigators (2015) Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Crit Care 19:7PubMedPubMedCentralCrossRefGoogle Scholar
  167. 167.
    Tortorano AM, Dho G, Prigitano A, Breda G, Grancini A, Emmi V, Cavanna C, Marino G, Morero S, Ossi C, Delvecchio G, Passera M, Cusumano V, David A, Bonaccorso G, Corona A, Favaro M, Vismara C, Garau MG, Falchi S, Tejada MR, ECMM-FIMUA Study Group (2012) Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008). Mycoses 55(1):73–79PubMedCrossRefGoogle Scholar
  168. 168.
    Wauters J, Baar I, Meersseman P, Meersseman W, Dams K, De Paep R, Lagrou K, Wilmer A, Jorens P, Hermans G (2012) Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med 38(11):1761–1768PubMedCrossRefGoogle Scholar
  169. 169.
    Baddley JW, Stephens JM, Ji X, Gao X, Schlamm HT, Tarallo M (2013) Aspergillosis in intensive care unit (ICU) patients: epidemiology and economic outcomes. BMC Infect Dis 13:29PubMedPubMedCentralCrossRefGoogle Scholar
  170. 170.
    Xu H, Li L, Huang WJ, Wang LX, Li WF, Yuan WF (2012) Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from China. Clin Microbiol Infect 18(4):403–408PubMedCrossRefGoogle Scholar
  171. 171.
    Denis B, Guiguet M, de Castro N, Mechaï F, Revest M, Melica G, Costagliola D, Lortholary O, French Hospital Database on HIV Agence Nationale de Recherche sur le SIDA et les hépatites virales, France CO4 (2015) Relevance of EORTC criteria for the diagnosis of invasive aspergillosis in HIV-infected patients, and survival trends over a 20-year period in France. Clin Infect Dis 61(8):1273–1280PubMedCrossRefGoogle Scholar
  172. 172.
    Chen J, Yang Q, Huang J, Li L (2013) Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study. Int J Med Sci 10(12):1625–1631PubMedPubMedCentralCrossRefGoogle Scholar
  173. 173.
    Chen J, Yang Q, Huang J, Li L (2014) Clinical findings in 19 cases of invasive pulmonary aspergillosis with liver cirrhosis. Multidiscip Respir Med 9(1):1PubMedPubMedCentralCrossRefGoogle Scholar
  174. 174.
    Shimodaira K, Okubo Y, Nakayama H, Wakayama M, Shinozaki M, Ishiwatari T, Sasai D, Nemoto T, Takahashi K, Ishii T, Saji T, Shibuya K (2012) Trends in the prevalence of invasive fungal infections from an analysis of annual records of autopsy cases of Toho University. Mycoses 55(5):435–443PubMedCrossRefGoogle Scholar
  175. 175.
    Dai Z, Zhao H, Cai S, Lv Y, Tong W (2013) Invasive pulmonary aspergillosis in non-neutropenic patients with and without underlying disease: a single-centre retrospective analysis of 52 subjects. Respirology 18(2):323–331PubMedCrossRefGoogle Scholar
  176. 176.
    Garnaud C, Brenier-Pinchart MP, Thiebaut-Bertrand A, Hamidfar R, Quesada JL, Bosseray A, Lebeau B, Mallaret MR, Maubon D, Saint-Raymond C, Pinel C, Hincky V, Plantaz D, Cornet M, Pelloux H (2012) Seven-year surveillance of nosocomial invasive aspergillosis in a French University Hospital. J Infect 65(6):559–567PubMedCrossRefGoogle Scholar
  177. 177.
    Haider S, Rotstein C, Horn D, Laverdiere M, Azie N (2014) The prospective antifungal therapy alliance® registry: a two-centre Canadian experience. Can J Infect Dis Med Microbiol 25(1):17–23PubMedPubMedCentralGoogle Scholar
  178. 178.
    Hsiue HC, Wu TH, Chang TC, Hsiue YC, Huang YT, Lee PI, Hsueh PR (2012) Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000-2009. Eur J Clin Microbiol Infect Dis 31(7):1319–1326PubMedCrossRefGoogle Scholar
  179. 179.
    Klingspor L, Saaedi B, Ljungman P, Szakos A (2015) Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009). Mycoses 58(8):470–477PubMedCrossRefGoogle Scholar
  180. 180.
    Montagna MT, Lovero G, Coretti C, Martinelli D, Delia M, De Giglio O, Caira M, Puntillo F, D’Antonio D, Venditti M, Sambri V, Di Bernardo F, Barbui A, Lo Cascio G, Concia E, Mikulska M, Viscoli C, Maximova N, Candoni A, Oliveri S, Lombardi G, Pitzurra L, Sanguinetti M, Masciari R, Santantonio T, Andreoni S, Barchiesi F, Pecile P, Farina C, Viale P, Specchia G, Caggiano G, Pagano L (2014) SIMIFF study: Italian fungal registry of mould infections in hematological and non-hematological patients. Infection 42(1):141–151Google Scholar
  181. 181.
    Nakamoto K, Takayanagi N, Kanauchi T, Ishiguro T, Yanagisawa T, Sugita Y (2013) Prognostic factors in 194 patients with chronic necrotizing pulmonary aspergillosis. Intern Med 52(7):727–734PubMedCrossRefGoogle Scholar
  182. 182.
    Ohba H, Miwa S, Shirai M, Kanai M, Eifuku T, Suda T, Hayakawa H, Chida K (2012) Clinical characteristics and prognosis of chronic pulmonary aspergillosis. Respir Med 106(5):724–729PubMedCrossRefGoogle Scholar
  183. 183.
    Steinbach WJ, Marr KA, Anaissie EJ, Azie N, Quan SP, Meier-Kriesche HU, Apewokin S, Horn DL (2012) Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH alliance registry. J Infect 65(5):453–464PubMedCrossRefGoogle Scholar
  184. 184.
    Wattier RL, Dvorak CC, Hoffman JA, Brozovich AA, Bin-Hussain I, Groll AH, Castagnola E, Knapp KM, Zaoutis TE, Gustafsson B, Sung L, Berman D, Halasa NB, Abzug MJ, Velegraki A, Sharma TS, Fisher BT, Steinbach WJ (2015) A prospective, international cohort study of invasive mould infections in children. J Pediatric Infect Dis Soc 4(4):313–322Google Scholar
  185. 185.
    Steinbach WJ (2010) Epidemiology of invasive fungal infections in neonates and children. Clin Microbiol Infect 16(9):1321–1327PubMedCrossRefGoogle Scholar
  186. 186.
    Crassard N, Hadden H, Piens MA, Pondarré C, Hadden R, Galambrun C, Pracros JP, Souillet G, Basset T, Berthier JC, Philippe N, Bertrand Y (2008) Invasive aspergillosis in a paediatric haematology department: a 15-year review. Mycoses 51(2):109–116PubMedCrossRefGoogle Scholar
  187. 187.
    Chamilos G, Luna M, Lewis RE, Bodey GP, Chemaly R, Tarrand JJ, Safdar A, Raad II, Kontoyiannis DP (2006) Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 91(7):986–989PubMedGoogle Scholar
  188. 188.
    Pagano L, Caira M, Nosari A, Van Lint MT, Candoni A, Offidani M, Aloisi T, Irrera G, Bonini A, Picardi M, Caramatti C, Invernizzi R, Mattei D, Melillo L, de Waure C, Reddiconto G, Fianchi L, Valentini CG, Girmenia C, Leone G, Aversa F (2007) Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study—Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 45(9):1161–1170PubMedCrossRefGoogle Scholar
  189. 189.
    Neofytos D, Fishman JA, Horn D et al (2010) Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis 12(3):220–229PubMedCrossRefGoogle Scholar
  190. 190.
    Kwon-Chung KJ (2012) Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives. Clin Infect Dis 54(Suppl 1):S8–S15PubMedPubMedCentralCrossRefGoogle Scholar
  191. 191.
    Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ (2005) Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41(5):634–653PubMedCrossRefGoogle Scholar
  192. 192.
    Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, Lass-Florl C, Bouza E, Klimko N, Gaustad P, Richardson M, Hamal P, Akova M, Meis JF, Rodriguez-Tudela JL, Roilides E, Mitrousia-Ziouva A, Petrikkos G (2011) European Confederation of Medical Mycology Working Group on Zygomycosis. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 17(12):1859–1867Google Scholar
  193. 193.
    Kontoyiannis DP, Azie N, Franks B, Horn DL (2014) Prospective antifungal therapy (PATH) alliance(®): focus on mucormycosis. Mycoses 57(4):240–246PubMedCrossRefGoogle Scholar
  194. 194.
    Rüping MJ, Heinz WJ, Kindo AJ, Rickerts V, Lass-Flörl C, Beisel C, Herbrecht R, Roth Y, Silling G, Ullmann AJ, Borchert K, Egerer G, Maertens J, Maschmeyer G, Simon A, Wattad M, Fischer G, Vehreschild JJ, Cornely OA (2010) Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother 65(2):296–302PubMedCrossRefGoogle Scholar
  195. 195.
    Klimko NN, Khostelidi SN, Volkova AG, Popova MO, Bogomolova TS, Zuborovskaya LS, Kolbin AS, Medvedeva NV, Zuzgin IS, Simkin SM, Vasilyeva NV, Afanasiev BV (2014) Mucormycosis in haematological patients: case report and results of prospective study in Saint Petersburg, Russia. Mycoses 57(Suppl 3):91–96PubMedCrossRefGoogle Scholar
  196. 196.
    Saegeman V, Maertens J, Ectors N, Meersseman W, Lagrou K (2010) Epidemiology of mucormycosis: review of 18 cases in a tertiary care hospital. Med Mycol 48(2):245–254PubMedCrossRefGoogle Scholar
  197. 197.
    Godara SM, Kute VB, Goplani KR, Gumber MR, Gera DN, Shah PR, Vanikar AV, Trivedi HL (2011) Mucormycosis in renal transplant recipients: predictors and outcome. Saudi J Kidney Dis Transpl 22(4):751–756PubMedGoogle Scholar
  198. 198.
    Ikram M, Iqbal M, Khan MA, Khan E, Shah M, Smego RA Jr (2011) Rhinocerebral zygomycosis in Pakistan: clinical spectrum, management, and outcome. J Pak Med Assoc 61(5):477–480PubMedGoogle Scholar
  199. 199.
    Chakrabarti A, Singh R (2014) Mucormycosis in India: unique features. Mycoses 57(Suppl 3):85–90PubMedCrossRefGoogle Scholar
  200. 200.
    Zaki SM, Elkholy IM, Elkady NA, Abdel-Ghany K (2014) Mucormycosis in Cairo, Egypt: review of 10 reported cases. Med Mycol 52(1):73–80PubMedGoogle Scholar
  201. 201.
    Bethge WA, Schmalzing M, Stuhler G, Schumacher U, Kröber SM, Horger M, Einsele H, Kanz L, Hebart H (2005) Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. Haematologica. (90 Suppl):ECR22Google Scholar
  202. 202.
    Candoni A, Caira M, Cesaro S, Busca A, Giacchino M, Fanci R, Delia M, Nosari A, Bonini A, Cattaneo C, Melillo L, Caramatti C, Milone G, Scime’ R, Picardi M, Fanin R, Pagano L, SEIFEM GROUP (Sorveglianza Epidemiologica Infezioni Fungine nelle Emopatie Maligne) (2014) Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real-life combo study. Mycoses 57(6):342–350Google Scholar
  203. 203.
    Hsieh TT, Tseng HK, Sun PL, Wu YH, Chen GS (2013) Disseminated zygomycosis caused by Cunninghamella bertholletiae in patient with hematological malignancy and review of published case reports. Mycopathologia 175(1–2):99–106PubMedCrossRefGoogle Scholar
  204. 204.
    Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S (2006) Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant 6(10):2365–2374PubMedCrossRefGoogle Scholar
  205. 205.
    Cuenca-Estrella M, Bernal-Martinez L, Isla G, Gomez-Lopez A, Alcazar-Fuoli L, Buitrago MJ (2009) Incidence of zygomycosis in transplant recipients. Clin Microbiol Infect 15(Suppl 5):37–40PubMedCrossRefGoogle Scholar
  206. 206.
    Phulpin-Weibel A, Rivier A, Leblanc T, Bertrand Y, Chastagner P (2013) Focus on invasive mucormycosis in paediatric haematology oncology patients: a series of 11 cases. Mycoses 56(3):236–240PubMedCrossRefGoogle Scholar
  207. 207.
    Zaoutis TE, Roilides E, Chiou CC, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Prasad PA, Chu JH, Walsh TJ (2007) Zygomycosis in children: a systematic review and analysis of reported cases. Pediatr Infect Dis J 26(8):723–727PubMedCrossRefGoogle Scholar
  208. 208.
    Neblett Fanfair R, Benedict K, Bos J, Bennett SD, Lo YC, Adebanjo T, Etienne K, Deak E, Derado G, Shieh WJ, Drew C, Zaki S, Sugerman D, Gade L, Thompson EH, Sutton DA, Engelthaler DM, Schupp JM, Brandt ME, Harris JR, Lockhart SR, Turabelidze G, Park BJ (2012) Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med 367(23):2214–2225PubMedCrossRefGoogle Scholar
  209. 209.
    Gerlach MM, Lippmann N, Kobelt L, Petzold-Quinque S, Ritter L, Kiess W, Siekmeyer M. Possible pulmonary Rhizopus oryzae infection in a previously healthy child after a near-drowning incident. Infection 2015. [Epub ahead of print]Google Scholar
  210. 210.
    Antoniadou A (2009) Outbreaks of zygomycosis in hospitals. Clin Microbiol Infect 15(Suppl 5):55–59PubMedCrossRefGoogle Scholar
  211. 211.
    Poirier P, Nourrisson C, Gibold L, Chalus E, Guelon D, Descamp S, Traore O, Cambon M, Aumeran C (2013) Three cases of cutaneous mucormycosis with Lichtheimia spp. (ex Absidia/Mycocladus) in ICU. Possible cross-transmission in an intensive care unit between 2 cases. J Mycol Med 23(4):265–269PubMedCrossRefGoogle Scholar
  212. 212.
    Duffy J, Harris J, Gade L, Sehulster L, Newhouse E, O’Connell H, Noble-Wang J, Rao C, Balajee SA, Chiller T (2014) Mucormycosis outbreak associated with hospital linens. Pediatr Infect Dis J 33(5):472–476PubMedCrossRefGoogle Scholar
  213. 213.
    Kanamori H, Rutala WA, Sickbert-Bennett EE, Weber DJ (2015) Review of fungal outbreaks and infection prevention in healthcare settings during construction and renovation. Clin Infect Dis 61(3):433–444PubMedCrossRefGoogle Scholar
  214. 214.
    Ambrosioni J, Bouchuiguir-Wafa K, Garbino J (2010) Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors. Int J Infect Dis 14(Suppl 3):e100–e103PubMedCrossRefGoogle Scholar
  215. 215.
    Vigouroux S, Morin O, Moreau P, Méchinaud F, Morineau N, Mahé B, Chevallier P, Guillaume T, Dubruille V, Harousseau JL, Milpied N (2005) Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. Clin Infect Dis 40(4):e35–e37, Epub 2005 Jan 25PubMedCrossRefGoogle Scholar
  216. 216.
    Suzuki K, Sugawara Y, Sekine T, Nakase K, Katayama N (2014) Breakthrough disseminated zygomycosis induced massive gastrointestinal bleeding in a patient with acute myeloid leukemia receiving micafungin. Kansenshogaku Zasshi 88(6 Suppl 11):11–14PubMedGoogle Scholar
  217. 217.
    Spellberg B, Kontoyiannis DP, Fredricks D, Morris MI, Perfect JR, Chin-Hong PV, Ibrahim AS, Brass EP (2012) Risk factors for mortality in patients with mucormycosis. Med Mycol 50(6):611–618PubMedPubMedCentralCrossRefGoogle Scholar
  218. 218.
    Spellberg B, Ibrahim AS, Chin-Hong PV, Kontoyiannis DP, Morris MI, Perfect JR, Fredricks D, Brass EP (2012) The deferasirox-AmBisome therapy for mucormycosis (DEFEAT mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother 67(3):715–722PubMedCrossRefGoogle Scholar
  219. 219.
    Nir-Paz R, Strahilevitz J, Shapiro M, Keller N, Goldschmied-Reouven A, Yarden O, Block C, Polacheck I (2004) J Clin Microbiol 42(8):3456–3461PubMedPubMedCentralCrossRefGoogle Scholar
  220. 220.
    Fleming RV, Walsh TJ, Anaissie E (2002) Emerging and less common fungal pathogens. J Infect Dis Clin North Am 16(4):915–933, vi-viiCrossRefGoogle Scholar
  221. 221.
    Berenguer J, Rodríguez-Tudela JL, Richard C, Alvarez M, Sanz MA, Gaztelurrutia L, Ayats J, Martinez-Suarez JV (1997) Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium prolificans Spanish Study Group. Medicine (Baltimore) 76(4):256–265Google Scholar
  222. 222.
    Idigoras P, Pérez-Trallero E, Piñeiro L, Larruskain J, López-Lopategui MC, Rodríguez N, González JM (2001) Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990-1999. Clin Infect Dis 32(11):E158–E165Google Scholar
  223. 223.
    Cortez KJ, Roilides E, Quiroz-Telles F, Meletiadis J, Antachopoulos C, Knudsen T, Buchanan W, Milanovich J, Sutton DA, Fothergill A, Rinaldi MG, Shea YR, Zaoutis T, Kottilil S, Walsh TJ (2008) Infections caused by Scedosporium spp. Clin Microbiol Rev 21(1):157–197Google Scholar
  224. 224.
    Johnson LS, Shields RK, Clancy CJ. Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients. Transpl Infect Dis 16(4):578–587Google Scholar
  225. 225.
    Park BJ, Pappas PG, Wannemuehler KA, Alexander BD, Anaissie EJ, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt L, Ito JI, Kauffman CA, Lyon GM, Marr KA, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wingard JR, Walsh TJ, Kontoyiannis DP (2011) Invasive non-Aspergillus mould infections in transplant recipients United States, 2001–2006. Emerg Infect Dis 17(10):1855–1864Google Scholar
  226. 226.
    Vargas SL, Hughes WT, Santolaya ME, Ulloa AV, Ponce CA, Cabrera CE, Cumsille F, Gigliotti F (2001) Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin Infect Dis 32(6):855–861Google Scholar
  227. 227.
    Larsen HH, von Linstow ML, Lundgren B, Høgh B, Westh H, Lundgren JD (2007) Primary pneumocystis infection in infants hospitalized with acute respiratory tract infection. Emerg Infect Dis 13(1):66–72PubMedPubMedCentralCrossRefGoogle Scholar
  228. 228.
    Pifer LL, Hughes WT, Stagno S, Woods D (1978) Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics 61:35–41Google Scholar
  229. 229.
    Navin TR, Rimland D, Lennox JL, Jernigan J, Cetron M, Hightower A, Roberts JM, Kaplan JE (2000) Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus. J Infect Dis 181(1):158–164PubMedCrossRefGoogle Scholar
  230. 230.
    Ruebush TK 2nd, Weinstein RA, Baehner RL, Wolff D, Bartlett M, Gonzles-Crussi F, Sulzer AJ, Schultz MG (1978) An outbreak of Pneumocystis pneumonia in children with acute lymphocytic leukemia. Am J Dis Child 132(2):143–148Google Scholar
  231. 231.
    Haron E, Bodey GP, Luna MA, Dekmezian R, Elting L (1988) Has the incidence of Pneumocystis carinii pneumonia in cancer patients increased with the AIDS epidemic? Lancet 2(8616):904–905Google Scholar
  232. 232.
    Cheung YF, Chan CF, Lee CW, Lau YL (1994) An outbreak of Pneumocystis carinii pneumonia in children with malignancy. J Paediatr Child Health 30(2):173–175Google Scholar
  233. 233.
    Olsson M, Eriksson BM, Elvin K, Strandberg M, Wahlgren M (2001) Genotypes of clustered cases of Pneumocystis carinii pneumonia. Scand J Infect Dis 33(4):285–289Google Scholar
  234. 234.
    Hennequin C, Page B, Roux P, Legendre C, Kreis H (1995) Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit. Eur J Clin Microbiol Infect Dis 14(2):122–126Google Scholar
  235. 235.
    Höcker B, Wendt C, Nahimana A, Tönshoff B, Hauser PM (2005) Molecular evidence of Pneumocystis transmission in pediatric transplant unit. Emerg Infect Dis 11(2):330–332Google Scholar
  236. 236.
    de Boer MG, Bruijnesteijn van Coppenraet LE, Gaasbeek A, Berger SP, Gelinck LB, van Houwelingen HC, van den Broek P, Kuijper EJ, Kroon FP, Vandenbroucke JP (2007) An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? Clin Infect Dis 44(9):1143–1149Google Scholar
  237. 237.
    Yazaki H, Goto N, Uchida K, Kobayashi T, Gatanaga H, Oka S (2009) Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host. Transplantation 88(3):380–385Google Scholar
  238. 238.
    Gianella S, Haeberli L, Joos B, Ledergerber B, Wüthrich RP, Weber R, Kuster H, Hauser PM, Fehr T, Mueller NJ (2010) Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients. Transpl Infect Dis 12(1):1–10Google Scholar
  239. 239.
    Rostved AA, Sassi M, Kurtzhals JA, Sørensen SS, Rasmussen A, Ross C, Gogineni E, Huber C, Kutty G, Kovacs JA, Helweg-Larsen J (2013) Outbreak of Pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii. Transplantation 96(9):834–842Google Scholar
  240. 240.
    Debourgogne A, Favreau S, Ladrière M, Bourry S, Machouart M (2014) Characteristics of Pneumocystis pneumonia in Nancy from January 2007 to April 2011 and focus on an outbreak in nephrology. J Mycol Med 24(1):19–24Google Scholar
  241. 241.
    Martin-Garrido I, Carmona EM, Specks U, Limper AH (2013) Pneumocystis pneumonia in patients treated with rituximab. Chest 144(1):258–265Google Scholar
  242. 242.
    de Boer MG, de Fijter JW, Kroon FP (2011) Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients: a systematic review. Med Mycol 49(7):673–680Google Scholar
  243. 243.
    Choukri F, Menotti J, Sarfati C, Lucet JC, Nevez G, Garin YJ, Derouin F, Totet A (2010) Quantification and spread of Pneumocystis jirovecii in the surrounding air of patients with Pneumocystis pneumonia. Clin Infect Dis 51(3):259–265Google Scholar
  244. 244.
    Davis JL, Welsh DA, Beard CB, Jones JL, Lawrence GG, Fox MR, Crothers K, Morris A, Charbonnet D, Swartzman A, Huang L (2008) Pneumocystis colonisation is common among hospitalised HIV infected patients with non-Pneumocystis pneumonia. Thorax 63(4):329–334Google Scholar
  245. 245.
    Masur H, Michelis MA, Greene JB, Onorato I, Stouwe RA, Holzman RS, Wormser G, Brettman L, Lange M, Murray HW, Cunningham-Rundles S (1981) An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med 305(24):1431–1438Google Scholar
  246. 246.
    Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338(13):853–860PubMedCrossRefGoogle Scholar
  247. 247.
    Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, Holmberg S, Jones JL (2000) Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 30(Suppl 1):S5–S14PubMedCrossRefGoogle Scholar
  248. 248.
    Kelley CF, Checkley W, Mannino DM, Franco-Paredes C, Del Rio C, Holguin F (2009) Trends in hospitalizations for AIDS-associated Pneumocystis jirovecii pneumonia in the United States (1986 to 2005). Chest 136(1):190–197Google Scholar
  249. 249.
    Walzer PD, Evans HE, Copas AJ, Edwards SG, Grant AD, Miller RF (2008) Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006. Clin Infect Dis 46(4):625–633Google Scholar
  250. 250.
    Fisk DT, Meshnick S, Kazanjian PH (2003) Pneumocystis cariniipneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin Infect Dis 36:70–78Google Scholar
  251. 251.
    Bakeera-Kitaka S, Musoke P, Downing R, Tumwine JK (2004) Pneumocystis carinii in children with severe pneumonia at Mulago Hospital. Uganda Ann Trop Paediatr 24(3):227–235Google Scholar
  252. 252.
    Kyeyune R, den Boon S, Cattamanchi A, Davis JL, Worodria W, Yoo SD, Huang L (2010) Causes of early mortality in HIV-infected TB suspects in an East African referral hospital. J Acquir Immune Defic Syndr 55(4):446–450PubMedPubMedCentralCrossRefGoogle Scholar
  253. 253.
    Serwadda D, Goodgame R, Lucas SKG (1989) Absence of pneumocystosis in Ugandan AIDS patients. AIDS 3:47–48PubMedCrossRefGoogle Scholar
  254. 254.
    Elvin KM, Lumbwe CM, Luo NP, Björkman A, LE Källenius G (1989) Pneumocystis carinii is not a major cause of pneumonia in HIV infected patients in Lusaka, Zambia. Trans R Soc Trop Med Hyg 83:553–555Google Scholar
  255. 255.
    Taylor SM, Meshnick SR, Worodria W, Andama A, Davis JL, Cattamanchi A, den Boon S, Yoo SD, Goodman CD, Huang L, International HIV-Associated Opportunistic Pneumonias (IHOP) Study (2012) Low prevalence of Pneumocystis jirovecii lung colonization in Ugandan HIV-infected patients hospitalized with non-Pneumocystis pneumonia. Diagn Microbiol Infect Dis 72(2):139–143Google Scholar
  256. 256.
    Jensen L, Jensen AV, Praygod G, Kidola J, Faurholt-Jepsen D, Changalucha J, Range N, Friis H, Helweg-Larsen J, Jensen JS, Andersen AB (2010) Infrequent detection of Pneumocystis jirovecii by PCR in oral wash specimens from TB patients with or without HIV and healthy contacts in Tanzania. BMC Infect Dis 10:140Google Scholar
  257. 257.
    Schoffelen AF, van Lelyveld SF, Barth RE, Gras L, de Wolf F, Netea MG, Hoepelman AI, ATHENA National Observational Cohort Study (2013) Lower incidence of Pneumocystis jirovecii pneumonia among Africans in the Netherlands host or environmental factors? AIDS 27(7):1179–1184Google Scholar
  258. 258.
    Hartung TK, Chimbayo D, van Oosterhout JJ, Chikaonda T, van Doornum GJ, Claas EC, Melchers WJ, Molyneux ME, Zijlstra EE (2011) Etiology of suspected pneumonia in adults admitted to a high-dependency unit in Blantyre, Malawi. Am J Trop Med Hyg 85(1):105–112. doi:  10.4269/ajtmh.2011.10-0640. Erratum in: Am J Trop Med Hyg. 2011;85(3):582
  259. 259.
    de Armas Rodríguez Y, Wissmann G, Müllera L, Pederiva MA, Brum MC, Brackmann RL, Capo de Paz V, Calderon EJ (2011) Pneumocystis jirovecii pneumonia in developing countries. Parasite 18:219–228Google Scholar
  260. 260.
    Marshall CS, Curtis AJ, Spelman T, O’Brien DP, Greig J, Shanks L, du Cros P, Casas EC, da Fonseca MS, Athan E, Elliott JH (2013) Impact of HIV-associated conditions on mortality in people commencing anti-retroviral therapy in resource limited settings. PLoS One 8(7):e68445PubMedPubMedCentralCrossRefGoogle Scholar
  261. 261.
    Revathy M, Therese KL, Bagyalakshmi R, Chandrasekar C, Kumar S, Madhavan HN (2014) Application of real time polymerase chain reaction targeting kex 1 gene and its comparison with the conventional methods for rapid detection of Pneumocystis jirovecii in clinical specimens. Indian J Med Res 140(3):406–413Google Scholar
  262. 262.
    Indira P, Kumar PM, Shalini S, Vaman K (2015) Opportunistic infections among people living with HIV (PLHIV) with diabetes mellitus (DM) attending a Tertiary Care Hospital in Coastal City of South India. PLoS One 10(8):e0136280PubMedPubMedCentralCrossRefGoogle Scholar
  263. 263.
    Stern A, Green H, Paul M, Vidal L, Leibovici L (2014) Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev 10:CD005590Google Scholar
  264. 264.
    Monnet X, Vidal-Petiot E, Osman D, Hamzaoui O, Durrbach A, Goujard C, Miceli C, Bourée P, Richard C (2008) Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection. Crit Care 12(1):R28Google Scholar
  265. 265.
    Festic E, Gajic O, Limper AH, Aksamit TR (2005) Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features. Chest 128(2):573–579PubMedCrossRefGoogle Scholar
  266. 266.
    Lopez-Martinez R, Mendez-Tovar LJ (2012) Blastomycosis. Clin Dermatol 30:565–572PubMedCrossRefGoogle Scholar
  267. 267.
    Richardson MD, Warnock DW (2012) Fungal infection. Diagnosis and management, 4th edn. Wiley-BlackwellGoogle Scholar
  268. 268.
    Fanella S, Skinner S, Trepman E, Embil JM (2011) Blastomycosis in children and adolescents: a 30-year experience from Manitoba. Med Mycol 49(6):627–632. doi: 10.3109/13693786.2010.547994, Epub 2011 Jan 5PubMedGoogle Scholar
  269. 269.
    Light BR, Kralt D, Embil JM, Trepman E, Wiebe L, Limerick B, Sarsfield P, Hammond G, Macdonald K (2008) Seasonal variations in the clinical presentation of pulmonary and extrapulmonary blastomycosis. Med Mycol 46(8):835–841. doi: 10.1080/13693780802132763 CrossRefGoogle Scholar
  270. 270.
    Savio J, Muralidharan S, Macaden RS, D’Souza G, Mysore S, Ramachandran P, Garg I, Rout P, Hemashettar BM, Padhye AA (2006) Blastomycosis in a South Indian patient after visiting an endemic area in USA. Med Mycol 44(6):523–529PubMedCrossRefGoogle Scholar
  271. 271.
    Roy M, Benedict K, Deak E et al (2013) A large community outbreak of blastomycosis in Wisconsin with geographic and ethnic clustering. Clin Infect Dis 57(5):655–662Google Scholar
  272. 272.
    Bradsher RW (2015) Chapter 266. Blastomycosis. In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell, Douglas and Bennett’s principles and practice of infectious diseases, 8th edn. Vol 2. Elsevier SaundersGoogle Scholar
  273. 273.
    Laniado-Laborin R (2007) Coccidioidomycosis and other endemic mycoses in Mexico. Rev Iberoam Micol 24:249–258PubMedCrossRefGoogle Scholar
  274. 274.
    Baptista-Rosas RC, Hinojosa A, Riquelme M (2007) Ecological niche modeling of Coccidioides spp. in western North American deserts. Ann N Y Acad Sci 1111:35–46, Epub 2007 Mar 29Google Scholar
  275. 275.
    Whiston E, Taylor JW (2014) Genomics in Coccidioides: insights into evolution, ecology, and pathogenesis. Med Mycol 52(2):149–155. doi: 10.1093/mmy/myt001, Epub 2013 Dec 12
  276. 276.
    Rodriguez-Cerdeira C, Arenas R, Moreno-Coutino G et al (2014) Systemic fungal infections in patients with human immunodeficiency virus. Actas Dermosifiliogr 105(1):5–17PubMedCrossRefGoogle Scholar
  277. 277.
    Azenha MR, Caliento R, Guilherme L et al (2012) A retrospective study of oral manifestations in patients with Paracoccidioidomycosis. Braz Dent J 23(6):753–757PubMedCrossRefGoogle Scholar
  278. 278.
    Andrade RV, da Silva SP, Torres FAG et al (2005) Overview and perspectives on the transcriptome of Paracoccidioides brasiliensis. Rev Iberoam Micol 22:203–212PubMedCrossRefGoogle Scholar
  279. 279.
    Shankar J, Restrepo A, Clemons KV et al (2011) Hormones and the resistance of women to paracoccidioidomycosis. Clin Microbiol Rev 24(2):296–313PubMedPubMedCentralCrossRefGoogle Scholar
  280. 280.
    Restrepo A, Tobon AM, Cano LE (2015) Chapter 269. Paracoccidioidomycosis. In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell, Douglas and Bennett’s principles and practice of infectious diseases, 8th edn. Vol 2. Elsevier SaundersGoogle Scholar
  281. 281.
    Chang P, Rodas C (2012) Skin lesions in histoplasmosis. Clin Dermatol 30(6):592–598. doi: 10.1016/j.clindermatol.2012.01.004 PubMedCrossRefGoogle Scholar
  282. 282.
    Leimann BCQ et al (2005) Histoplasmosis in a Brazilian center: clinical forms and laboratory tests. Rev Iberoam Micol 22:141–146PubMedCrossRefGoogle Scholar
  283. 283.
    Steenbergen JN, Nosanchuk JD, Malliaris SD et al (2004) Interaction of Blastomyces dermatitidis, Sporothrix schenckii and Histoplasma capsulatum with Acanthamoeba castellani. Infect Immun 72(6):3478–3488Google Scholar
  284. 284.
    Smith ES, Fleischer AB, Feldman SR, Williford PM (2002) Characteristics of office-based physician visits for cutaneous fungal infections. an analysis of 1990 to 1994 National Ambulatory Medical Care Survey Data. Cutis 69(3):191–198, 201-2PubMedGoogle Scholar
  285. 285.
    Akiba H, Motoki Y, Satoh M, Iwatsuki K, Kaneko F (2001) Recalcitrant trichophytic granuloma associated with NK-cell deficiency in a SLE patient treated with corticosteroid. Eur J Dermatol 11(1):58–62PubMedGoogle Scholar
  286. 286.
    Lee WJ, Kim SL, Jang YH, Lee SJ, Kim do W, Bang YJ, Jun JB (2015) Increasing prevalence of Trichophyton rubrum identified through an analysis of 115,846 cases over the last 37 years. J Korean Med Sci 30(5):639–643PubMedPubMedCentralCrossRefGoogle Scholar
  287. 287.
    Marconi VC, Kradin R, Marty FM, Hospenthal DR, Kotton CN (2010) Disseminated dermatophytosis in a patient with hereditary hemochromatosis and hepatic cirrhosis: case report and review of the literature. Med Mycol 48(3):518–527. doi: 10.3109/13693780903213512 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • David A. Enoch
    • 1
    Email author
  • Huina Yang
    • 1
  • Sani H. Aliyu
    • 1
  • Christianne Micallef
    • 1
  1. 1.National Infection Service, Public Health England, Cambridge Microbiology and Public Health LaboratoryAddenbrooke’s HospitalCambridgeUK

Personalised recommendations